Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-23-000070

EVP, Quality & Ethics, and CPL acquired 11,538 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Glessner Coleen · EVP, Quality & Ethics, and CPL

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2023-03-02 Grant or award : show line 1 in the form +3,846 111,982 D
2023-03-02 Grant or award : show line 2 in the form +7,692 119,674 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-02 Grant or award : show line 3 in the form Employee Stock Options (Right to Buy) +7,692 31,343 D
Loading xslF345X03/wf-form4_167814940093617.xml…